 BIOLASE, Inc. NASDAQ: BIOL, the global leader in dental lasers, today announced data published in the Journal of Periodontology from a clinical trial conducted at The McGuire InstituteTM. Designed to meet the stringent American Association of Periodontology Best Evidence Consensus BEC standards, this first-of-its-kind study compared BIOLASEs REPAIR Perio protocol to the traditional Minimally Invasive Surgical Technique MIST treatment of moderate to severe generalized periodontitis. 